MicroRNA‐33b replacement effect on growth and migration inhibition in ovarian cancer cells
Jin Liu et al, 2023, Chemical Biology & Drug Design CrossRef
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints
Daniele Fanale et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
Multiple roles of mothers against decapentaplegic homolog 4 in tumorigenesis, stem cells, drug resistance, and cancer therapy
Chuan-Jing Dai et al, 2022, World Journal of Stem Cells CrossRef
Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis
Yu Sun et al, 2020, BioMed Research International CrossRef
MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis
Aryan Rezaee et al, 2023, Frontiers in Oncology CrossRef
PREDICTIVE RELAPSE MODEL IN PATIENTS WITH LUMINAL HER2-NEGATIVE BREAST CANCER
M.Kh. Torosyan et al, 2020, Ulyanovsk Medico-biological Journal CrossRef
ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance
David C. Stieg et al, 2022, International Journal of Molecular Sciences CrossRef
Diagnostics and Therapeutic Potential of miR-205 and miR-34a in Ovarian Cancer Management: A miRNA-Target-Based Analysis
Vivek Kumar et al, 2023, DNA and Cell Biology CrossRef
miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells
Xiaoyan Shi et al, 2018, Frontiers in Genetics CrossRef
Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer
Vivek Kumar et al, 2021, Frontiers in Oncology CrossRef
Circulating and Tissue microRNAs as Biomarkers for Ovarian Cancer Prognosis
Seyed Mostafa Parizadeh et al, 2019, Current Drug Targets CrossRef
Improving Recurrence Prediction Accuracy of Ovarian Cancer Using Multi-phase Feature Selection Methodology
S. Sujamol et al, 2021, Applied Artificial Intelligence CrossRef